Oklo and Centrus Sign Letter of Intent for HALEU Supply
Oklo (OKLO) and Centrus Energy (LEU) announced a Letter of Intent under which Centrus agrees to supply enough domestic high-assay low-enriched uranium (HALEU) to power up to five Aurora powerhouses for multiple years, with deliveries to Oklo scheduled to begin in 2029. Centrus will supply HALEU from its American Centrifuge Plant in Pike County, Ohio to support Oklo's planned 1.2 GW power campus in the region. The agreement, which anticipates a further definitive contract, brings together domestic fuel supply, planned advanced nuclear power generation, customer demand, and project execution in southern Ohio while strengthening fuel certainty for Oklo's planned Aurora powerhouse deployments at a time when access to domestically sourced HALEU remains one of the central constraints facing the advanced nuclear sector. The Letter of Intent could include prepayments from Oklo to Centrus to support fuel supply for Oklo's planned campus buildout and will be further negotiated in a future definitive agreement. It follows Oklo's January 2026 announcement with Meta, which included prepayment to advance project certainty for Oklo's planned Aurora powerhouse campus. Centrus plans to leverage billions in private capital along with the previously announced $900 million HALEU task order from the U.S. Department of Energy.
Trade with 70% Backtested Accuracy
Analyst Views on OKLO
About OKLO
About the author

- Significant Market Potential: Oklo's Aurora microreactor can connect multiple units to generate up to 75 MWe per 'Powerhouse' plant, which, while significantly lower than conventional nuclear plants' 1,000 MWe, is better suited for building smaller plants in remote areas, addressing future energy demands.
- Fuel Advantages: The Aurora operates on metallic uranium fuel pellets that offer higher thermal resistance and lower fabrication costs compared to traditional uranium dioxide pellets, allowing for a decade of operation without refueling, thus enhancing operational efficiency and economic viability.
- Critical Testing Ahead: If Oklo passes the U.S. Department of Energy's criticality test by the July 4 deadline, it will accelerate its Reactor Pilot Program for nuclear testing, paving the way for the deployment of its first Powerhouse reactors in Idaho by 2027, marking a significant milestone.
- Revenue Growth Expectations: Analysts project Oklo's revenue to surge from $4.6 million in 2027 to $51.3 million in 2028, and with the global microreactor market expected to grow at a 24.3% CAGR, Oklo is positioned for potential multibagger returns over the next decade.
- Nuclear Market Potential: Oklo and NuScale are developing small modular reactors (SMRs), and while their technology is promising, both companies are currently unprofitable, indicating a high-risk investment landscape that requires caution from investors.
- Brookfield's Advantage: Brookfield Renewable focuses on renewable energy with a global portfolio that includes hydroelectric, solar, and wind assets, while also owning 50% of Westinghouse, a company with a long-standing presence in the nuclear power sector.
- Balancing Returns and Risks: Unlike pure nuclear investments, Brookfield's profitable business model is built on well-established assets, offering a stable dividend yield of approximately 4.5%, making it suitable for conservative investors and mitigating investment risks.
- AI-Driven Energy Demand: Brookfield expands its exposure to nuclear and clean energy demand through power supply agreements with Microsoft and Google, showcasing broader investment opportunities in the AI-driven market compared to investing in pure-play nuclear stocks.
- Nuclear Market Performance: Over the past year, nuclear energy stocks have outperformed the broader energy sector, highlighting the increasing relevance of nuclear power in the context of power-hungry technologies like AI and cloud computing.
- Oklo's Progress: Oklo is designing small fast-fission reactors and has signed agreements with companies like Equinix, Switch, and Meta; while still needing regulatory approval, its technology could become a significant player in the AI era.
- Nano Nuclear Energy's Diversification: Nano Nuclear Energy focuses on diverse designs of microreactors and aims to participate in multiple segments of the nuclear supply chain; although still navigating regulatory processes, its space microreactor design could attract more interest.
- NuScale Power's Commercial Challenges: NuScale's modular reactors have received regulatory approval, but the challenge lies in commercialization; potential collaboration with the Tennessee Valley Authority offers future opportunities, yet revenue growth may not materialize until after 2030.
- SMR Development: Oklo and NuScale Power are developing small modular reactors (SMRs), and while both companies are startups currently operating at a loss, their technological prospects are widely regarded as promising, potentially reshaping the nuclear energy market in the future.
- Renewable Energy Investment: Brookfield Renewable showcases strong profitability through its global portfolio of clean energy assets, including hydroelectric, solar, and wind, while also holding a 50% stake in Westinghouse, which has a long-standing history in the nuclear power industry, further solidifying its market position.
- AI-Driven Demand Growth: As the AI revolution drives demand for both nuclear and clean energy, Brookfield Renewable not only offers a stable dividend yield (around 4.5%) but also provides investors with broader market exposure, mitigating the risks associated with investing solely in nuclear power.
- Investment Strategy Adjustment: Despite the untested nature of Oklo and NuScale's technologies at scale, Brookfield Renewable's robust business model and profitability make it a more suitable choice for conservative investors, ensuring opportunities to benefit from the growing demand for nuclear energy.
- Stock Surge: Nano Nuclear Energy (NNE) shares have surged approximately 15% over the past month, currently priced at $28.21, reflecting strong market confidence in its future potential despite only a 2% year-to-date increase.
- Analyst Price Target: A bullish price target of $45 from Roth Capital implies an 87% upside from its previous $24 price, generating significant enthusiasm among investors eager for high returns.
- Microreactor Development Progress: The Kronos MMR microreactor has cleared a crucial regulatory hurdle with the NRC's acceptance of its construction permit in April 2023, with prototype construction expected to begin at the University of Illinois by mid to late 2027, marking a significant step in the nuclear supply chain.
- Market Outlook and Risks: While the prospects for Nano Nuclear Energy in the clean energy sector are promising, its success hinges on the market introduction of a safe, certified microreactor, presenting both investment risks and potential rewards that require careful evaluation.
- Market Recovery: Nano Nuclear Energy (NASDAQ: NNE) has seen its stock rise approximately 15% over the past month and about 2% year-to-date, reflecting optimistic market sentiment regarding its growth potential, particularly after an analyst set a bullish price target of $45, implying an upside of around 87%.
- Microreactor Designs: The company has three main microreactor designs, including Kronos MMR, Zeus, and Loki MMR, with Kronos being the furthest along in development, having received construction permit acceptance from the Nuclear Regulatory Commission, with prototype construction expected to begin at the University of Illinois in mid to late 2027.
- Vertical Integration Strategy: Nano Nuclear Energy aims to not only design and build reactors but also engage in fuel fabrication and transportation, intending to create a deep market moat through this vertical integration strategy, which could attract customers seeking comprehensive service.
- AI and Nuclear Synergy: While the market is excited about the potential of nuclear energy as a clean power source for data centers, this vision has yet to materialize, and Nano's success hinges on its ability to safely and effectively bring microreactors to market, presenting both risks and opportunities.








